Total Payments
$2,772
2023 Payments
$131.85
Companies
24
Transactions
168
Medicare Patients
847
Medicare Billing
$138,512
Payment Breakdown by Category
Food & Beverage$2,729 (98.4%)
Education$43.37 (1.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,729 | 166 | 98.4% |
| Education | $43.37 | 2 | 1.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Celgene Corporation | $635.52 | 45 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $421.27 | 26 | $0 (2023) |
| Eisai Inc. | $245.90 | 16 | $0 (2020) |
| E.R. Squibb & Sons, L.L.C. | $245.38 | 17 | $0 (2020) |
| Amgen Inc. | $242.61 | 15 | $0 (2023) |
| Galvanize Therapeutics, Inc | $152.02 | 1 | $0 (2022) |
| Novocure Inc. | $135.39 | 4 | $0 (2023) |
| Puma Biotechnology, Inc. | $125.75 | 8 | $0 (2023) |
| Merck Sharp & Dohme Corporation | $107.65 | 8 | $0 (2019) |
| Janssen Biotech, Inc. | $72.92 | 4 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $131.85 | 6 | Daiichi Sankyo Inc. ($46.89) |
| 2022 | $277.26 | 5 | Galvanize Therapeutics, Inc ($152.02) |
| 2020 | $253.96 | 15 | AstraZeneca Pharmaceuticals LP ($64.61) |
| 2019 | $968.62 | 63 | Celgene Corporation ($210.62) |
| 2018 | $720.27 | 48 | Celgene Corporation ($255.64) |
| 2017 | $420.37 | 31 | Celgene Corporation ($169.26) |
All Payment Transactions
168 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2023 | Puma Biotechnology, Inc. | — | Food and Beverage | In-kind items and services | $16.77 | General |
| 07/27/2023 | Novocure Inc. | Optune (Device) | Food and Beverage | Cash or cash equivalent | $26.33 | General |
| Category: Oncology | ||||||
| 05/03/2023 | Daiichi Sankyo Inc. | — | Food and Beverage | In-kind items and services | $19.91 | General |
| 03/01/2023 | Daiichi Sankyo Inc. | Enhertu (Drug) | Education | In-kind items and services | $26.98 | General |
| Category: ONCOLOGY | ||||||
| 03/01/2023 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Food and Beverage | In-kind items and services | $22.09 | General |
| Category: Oncology | ||||||
| 02/22/2023 | Amgen Inc. | Nplate (Biological), Vectibix, XGEVA | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: Hematology | ||||||
| 11/15/2022 | Galvanize Therapeutics, Inc | ALIYA SYSTEM (Device) | Food and Beverage | In-kind items and services | $152.02 | General |
| Category: PULSED ELECTRIC FIELD | ||||||
| 06/28/2022 | Karyopharm Therapeutics Inc. | XPOVIO (Drug) | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: Oncology | ||||||
| 05/19/2022 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $29.55 | General |
| Category: Heart Failure | ||||||
| 03/16/2022 | Novocure Inc. | NovoTTF-100L (Device) | Food and Beverage | Cash or cash equivalent | $67.03 | General |
| Category: Oncology | ||||||
| 01/05/2022 | Ambu Inc. | — | Food and Beverage | Cash or cash equivalent | $9.80 | General |
| 03/11/2020 | Amgen Inc. | KANJINTI (Biological), MVASI, Neulasta | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: Oncology | ||||||
| 03/04/2020 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $19.88 | General |
| Category: Oncology | ||||||
| 03/03/2020 | AstraZeneca Pharmaceuticals LP | IMFINZI (Drug) | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: Oncology | ||||||
| 02/28/2020 | Jazz Pharmaceuticals Inc. | VYXEOS (Drug) | Food and Beverage | In-kind items and services | $24.09 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 02/25/2020 | Foundation Medicine, Inc. | FOUNDATIONONE (Device), FOUNDATIONONE HEME, FOUNDATIONONE CDX | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: ONCOLOGY | ||||||
| 02/21/2020 | Amgen Inc. | Kyprolis (Drug) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: Oncology | ||||||
| 02/19/2020 | Bayer HealthCare Pharmaceuticals Inc. | Vitrakvi (Drug) | Food and Beverage | In-kind items and services | $11.12 | General |
| Category: Oncology | ||||||
| 02/18/2020 | Bayer HealthCare Pharmaceuticals Inc. | Vitrakvi (Drug) | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: Oncology | ||||||
| 02/07/2020 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: Oncology | ||||||
| 02/04/2020 | Puma Biotechnology, Inc. | NERLYNX (Drug) | Food and Beverage | In-kind items and services | $15.17 | General |
| Category: ONCOLOGY | ||||||
| 01/29/2020 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $16.74 | General |
| 01/20/2020 | Janssen Biotech, Inc. | BALVERSA (Drug) | Food and Beverage | In-kind items and services | $21.68 | General |
| Category: Oncology | ||||||
| 01/08/2020 | Eisai Inc. | Halaven (Drug) | Food and Beverage | Cash or cash equivalent | $15.42 | General |
| Category: Oncology | ||||||
| 01/07/2020 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 207 | 532 | $115,009 | $34,576 |
| 2022 | 9 | 216 | 475 | $121,377 | $36,092 |
| 2021 | 9 | 190 | 362 | $88,431 | $27,343 |
| 2020 | 9 | 234 | 531 | $138,334 | $40,501 |
Total Patients
847
Total Services
1,900
Medicare Billing
$138,512
Procedure Codes
35
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 77427 | Radiation treatment management, 5 treatment sessions | Office | 2023 | 22 | 74 | $42,772 | $11,803 | 27.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 86 | 115 | $13,570 | $5,740 | 42.3% |
| 77014 | Ct guidance for insertion of radiation therapy fields | Office | 2023 | 11 | 133 | $17,822 | $4,865 | 27.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 27 | 27 | $10,530 | $3,954 | 37.6% |
| 77263 | Complex radiation therapy planning | Office | 2023 | 17 | 18 | $9,324 | $2,570 | 27.6% |
| 77300 | Calculation of radiation therapy dose | Office | 2023 | 15 | 92 | $9,108 | $2,560 | 28.1% |
| 77334 | Design and construction of complex radiation treatment device | Office | 2023 | 15 | 45 | $8,775 | $2,187 | 24.9% |
| 77280 | Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | Office | 2023 | 14 | 28 | $3,108 | $898.52 | 28.9% |
| 77427 | Radiation treatment management, 5 treatment sessions | Office | 2022 | 21 | 88 | $50,864 | $14,217 | 28.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 82 | 98 | $11,564 | $5,101 | 44.1% |
| 77334 | Design and construction of complex radiation treatment device | Office | 2022 | 16 | 89 | $17,355 | $4,515 | 26.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 22 | 22 | $8,580 | $3,432 | 40.0% |
| 77300 | Calculation of radiation therapy dose | Office | 2022 | 19 | 105 | $10,395 | $2,879 | 27.7% |
| 77263 | Complex radiation therapy planning | Office | 2022 | 18 | 20 | $10,360 | $2,847 | 27.5% |
| 77295 | 3d radiation therapy planning | Office | 2022 | 11 | 11 | $7,997 | $1,976 | 24.7% |
| 77280 | Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | Office | 2022 | 14 | 26 | $2,886 | $801.11 | 27.8% |
| 77332 | Design and construction of simple radiation treatment device | Office | 2022 | 13 | 16 | $1,376 | $322.44 | 23.4% |
| 77427 | Radiation treatment management, 5 treatments | Office | 2021 | 15 | 60 | $31,212 | $9,124 | 29.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 77 | 95 | $11,210 | $4,979 | 44.4% |
| 77334 | Radiation treatment devices, design and construction, complex | Office | 2021 | 15 | 66 | $12,870 | $3,392 | 26.4% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 18 | 18 | $7,020 | $2,857 | 40.7% |
| 77263 | Management of radiation therapy, complex | Office | 2021 | 14 | 15 | $7,770 | $2,165 | 27.9% |
| 77295 | Management of radiation therapy, 3d | Office | 2021 | 12 | 12 | $8,724 | $2,136 | 24.5% |
| 77300 | Calculation of radiation therapy dose | Office | 2021 | 13 | 63 | $6,237 | $1,749 | 28.0% |
| 77280 | Management of radiation therapy simulation, simple | Office | 2021 | 15 | 22 | $2,442 | $716.98 | 29.4% |
About Dr. Deborah Markiewicz, MD
Dr. Deborah Markiewicz, MD is a Radiation Oncology healthcare provider based in Drexel Hill, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/29/2005. The National Provider Identifier (NPI) number assigned to this provider is 1780684845.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Deborah Markiewicz, MD has received a total of $2,772 in payments from pharmaceutical and medical device companies, with $131.85 received in 2023. These payments were reported across 168 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($2,729).
As a Medicare-enrolled provider, Markiewicz has provided services to 847 Medicare beneficiaries, totaling 1,900 services with total Medicare billing of $138,512. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Ad
Practice Information
- Specialty Radiation Oncology
- Location Drexel Hill, PA
- Active Since 07/29/2005
- Last Updated 07/08/2007
- Taxonomy Code 2085R0001X
- Entity Type Individual
- NPI Number 1780684845
Products in Payments
- Abraxane (Drug) $377.28
- OPDIVO (Biological) $245.38
- Halaven (Drug) $231.80
- TAGRISSO (Drug) $164.98
- ALIYA SYSTEM (Device) $152.02
- Revlimid (Drug) $149.18
- IMFINZI (Drug) $116.70
- KEYTRUDA (Biological) $107.65
- Nerlynx (Drug) $93.81
- Neulasta (Biological) $78.60
- CALQUENCE (Drug) $67.51
- NovoTTF-100L (Device) $67.03
- VYXEOS (Drug) $62.06
- Pomalyst (Drug) $60.33
- Vitrakvi (Drug) $60.05
- Balversa (Drug) $51.24
- KANJINTI (Biological) $45.17
- Oncology (Device) $42.03
- Kyprolis (Biological) $38.04
- ADCETRIS (Biological) $37.27
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.